Thrombophilia screening among eight individuals who developed VTE revealed that two were heterozygous for the Factor V Leiden mutation, three tested positive for lupus anticoagulant antibodies, two had anticardiolipin antibodies, and two tested positive for anti-beta-2 glycoprotein I (anti-β2GPI) antibodies. This evidence concerns the gene APOH and Rare hereditary thrombophilia.